Side-by-side comparison of AI visibility scores, market position, and capabilities
US energy drink leader with $7.5B FY2024 revenue; Coca-Cola strategic partner (16.7% stake + global distribution); Bang acquisition 2023; competes with Celsius's fitness-focused challenger rise.
Monster Beverage Corporation is the world's leading energy drink company by market share in the United States, founded in 1935 as Hansen's Natural and rebranded to Monster Beverage in 2012, headquartered in Corona, California and trading on Nasdaq (MNST). The company generated approximately $7.5 billion in net sales for FY2024 under co-CEOs Hilton Schlosberg and Rob Sacks, with Monster Energy remaining the best-selling energy drink in the U.S. and the second globally behind Red Bull. A strategic partnership with Coca-Cola, which acquired a 16.7% stake in Monster in 2015 for approximately $2.15 billion and provides Monster with Coca-Cola's global distribution infrastructure, has been the foundational driver of Monster's international expansion across more than 150 countries.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.